RBM8A and ovarian cancer: The expression of the RBM8A mRNA level had no significant influence in breast cancer (P = 0.48), head neck squamous cell carcinoma (P = 0.32), esophageal squamous cell carcinoma (P = 0.082), ovarian cancer (P = 0.05), stomach adenocarcinoma (P = 0.25), rectum adenocarcinoma (P = 0.36), thymoma (P = 0.28), thyroid carcinoma (P = 0.2), or uterine corpus endometrial carcinoma (P = 0.088).